The direct hepatoprotective effects of IL-22 have been investigated in multiple models of liver injuries, including T cell-mediated hepatitis (42), acetaminophen-induced liver injury (43, 44), fatty liver disease (45–47), and AH (48). The gene discussed is IL22; the disease is fatty liver disease.